Connealy Pamela Yanchik

Chief Financial Officer, Immunovant, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 23, 2026Granted 17,327 shares of Orchestra BioMed Holdings, Inc.⁶
Aug 7, 2025Granted 15,000 shares of Orchestra BioMed Holdings, Inc.⁷
Jun 24, 2025Granted 12,422 shares of Orchestra BioMed Holdings, Inc.⁸
Nov 26, 2024Bought 83,400 shares at $1.96 of Pyxis Oncology, Inc.⁵
Nov 26, 2024Bought 5,450 shares at $2.00 of Pyxis Oncology, Inc.⁵
Jun 20, 2024Granted 5,376 shares of Orchestra BioMed Holdings, Inc.⁹
Mar 26, 2024Granted 328,710 shares of Pyxis Oncology, Inc.¹⁰
Nov 29, 2023Shares withheld for tax 36,949 shares at $1.40 of Pyxis Oncology, Inc.¹¹
Sep 28, 2023Bought 8,000 shares at $1.87 of Pyxis Oncology, Inc.¹²
Sep 27, 2023Bought 6,426 shares at $1.85 of Pyxis Oncology, Inc.¹³
Sep 25, 2023Bought 12,000 shares at $1.67 of Pyxis Oncology, Inc.¹⁴
Sep 22, 2023Bought 5,000 shares at $1.74 of Pyxis Oncology, Inc.¹⁵
Sep 7, 2023Granted 187,793 shares of Pyxis Oncology, Inc.¹⁶
Jul 20, 2023Granted 11,667 shares of Orchestra BioMed Holdings, Inc.¹⁷
Apr 12, 2023Exercised options 758 shares of Orchestra BioMed Holdings, Inc.¹⁸
Mar 24, 2023Granted 209,803 shares of Pyxis Oncology, Inc.¹⁹
Jan 26, 2023Granted 3,488 shares of Orchestra BioMed Holdings, Inc.²⁰
Jan 3, 2023Granted 43,493 shares of Pyxis Oncology, Inc.²¹
Apr 14, 2022Granted 93,493 shares of Pyxis Oncology, Inc.²²
Mar 31, 2022Granted 247,524 shares of Pyxis Oncology, Inc.²³

The numbers on this page point here. Each one links to the record it came from.